All Stories

  1. Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes
  2. Interaction of 7-Alkoxycoumarins with the Aryl Hydrocarbon Receptor
  3. PCSK9 at the crossroad of cholesterol metabolism and immune function during infections
  4. Neopterin and tryptophan breakdown in medical biochemistry, workshop abstracts
  5. Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1
  6. Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db/db mice with spontaneous diabetes mellitus
  7. Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial
  8. Aryl Hydrocarbon Receptor-Dependent Pathways in Immune Regulation
  9. Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells
  10. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis
  11. Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype
  12. caffeine
  13. Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice
  14. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE
  15. Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice
  16. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII
  17. Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy
  18. Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers
  19. Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3‐dioxygenase1
  20. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ
  21. In vitro cadmium effects on ECM gene expression in human bronchial epithelial cells
  22. The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors
  23. LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism
  24. Comparative proteomic analysis of two distinct stem-cell populations from human amniotic fluid
  25. Tryptophan Feeding of the IDO1-AhR Axis in Host–Microbial Symbiosis
  26. Ligand Binding and Functional Selectivity of l-Tryptophan Metabolites at the Mouse Aryl Hydrocarbon Receptor (mAhR)
  27. AhR-Mediated, Non-Genomic Modulation of IDO1 Function
  28. Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes
  29. AhR: Far more than an environmental sensor
  30. Aryl hydrocarbon receptor control of a disease tolerance defence pathway
  31. Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice
  32. Distinct and complementary roles for Aspergillus fumigatus ‐specific Tr1 and Foxp3 + regulatory T cells in humans and mice
  33. Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
  34. NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells
  35. On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness
  36. Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
  37. Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival
  38. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway
  39. Th17/Treg Imbalance in Murine Cystic Fibrosis Is Linked to Indoleamine 2,3-Dioxygenase Deficiency but Corrected by Kynurenines
  40. Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy
  41. A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-� AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS
  42. Jack of all trades: thymosin α1 and its pleiotropy
  43. Targeting metabotropic glutamate receptors in neuroimmune communication
  44. Indoleamine 2,3-dioxygenase: From catalyst to signaling function
  45. A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression
  46. Prolongation of skin allograft survival in rats by the transplantation of microencapsulated xenogeneic neonatal porcine Sertoli cells
  47. TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients
  48. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
  49. Xenograft of Microencapsulated Sertoli Cells Reverses T1DM in NOD Mice by Inducing Neogenesis of Beta-Cells
  50. IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis
  51. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation
  52. Correction: IDO Mediates Tlr9-Driven Protection From Experimental Autoimmune Diabetes
  53. IL-22 defines a novel immune pathway of antifungal resistance
  54. Thymosin α1: the regulator of regulators?
  55. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction
  56. Bioactive Long-Term Release from Biodegradable Microspheres Preserves Implanted ALG-PLO-ALG Microcapsules from In Vivo Response to Purified Alginate
  57. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis
  58. IDO Mediates TLR9-Driven Protection from Experimental Autoimmune Diabetes
  59. Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone
  60. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans
  61. Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host
  62. Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy toAspergillus
  63. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
  64. Melanoma presenting as circulating tumor cells associated with failed angiogenesis
  65. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism
  66. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
  67. Immunosuppression Via Tryptophan Catabolism: The Role of Kynurenine Pathway Enzymes
  68. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
  69. Tryptophan Catabolism in IDO+ Plasmacytoid Dendritic Cells
  70. Innovative extraction procedure for obtaining high pure lycopene from tomato
  71. Tryptophan catabolism generates autoimmune-preventive regulatory T cells
  72. Thymosin  1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance
  73. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
  74. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism
  75. Mechanisms of CTLA-4-Ig in Tolerance Induction
  76. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12
  77. Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines
  78. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
  79. CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig
  80. The 2004 FASEB Summer Research Conference on Transplant Immunology: Closer to the Goal of Transplant-Specific Tolerance
  81. CTLA-4–Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice
  82. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86
  83. TOLERANCE, DENDRITIC CELLS AND TRYPTOPHAN
  84. Modulation of tryptophan catabolism by regulatory T cells
  85. A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice
  86. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
  87. Response to von Bubnoff et al.: Still new perspectives on IDO function?
  88. New jobs for an old enzyme: the revival of IDO
  89. Tolerance, DCs and tryptophan: much ado about IDO
  90. Tryptophan Catabolism in Nonobese Diabetic Mice
  91. T Cell Apoptosis by Kynurenines
  92. CTLA-4–Ig regulates tryptophan catabolism in vivo
  93. T cell apoptosis by tryptophan catabolism
  94. Transplantation and the CD28/CTLA4/B7 pathway
  95. Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12
  96. B7-1 Engagement of Cytotoxic T Lymphocyte Antigen 4 Inhibits T Cell Activation in the Absence of CD28
  97. Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells
  98. Receptors and Pathways in Innate Antifungal Immunity